Advertisement
Screener

EMBECTA CORP. (EMBC) Cash Flow Breakdown

2.8 / 5 stars · 68/120 Roast Me

EMBECTA CORP. Cash Flow Breakdown

Cash flow breakdown shows where EMBECTA CORP.'s cash came from and where it went: from running the business, from investing (buying or selling equipment, companies and investments) and from financing (borrowing, paying back loans, buying back shares, paying dividends). One row per year or quarter. A minus sign means cash went out. Financing is shown line by line: buybacks, dividends, debt paid back, new debt and the rest. All amounts are the filed figures for that period.

  • Fiscal year ended 2025-09-30: from running the business, $191.70M came in.
  • Fiscal year ended 2025-09-30: from investing, $9.30M went out.
  • Fiscal year ended 2025-09-30: from financing, $226.70M went out.
  • Fiscal year ended 2025-09-30: change in cash, $45.60M went out.

A minus sign means cash went out. * = worked out from the filed year-to-date figures (hover to see how); greyed = already counted inside another line.

Each year (12 month)

Fiscal year endRunning the businessFrom investingDividendsDebt paid backNew debtStaff share taxNot split outChange in cash
2025-09-30$191.70M-$9.30M-$35.00M-$184.60M-$5.70M-$1.40M*-$45.60M
2024-09-30$35.70M-$15.80M-$34.50M-$34.60M$0.00-$3.00M-$1.30M*-$52.30M
2023-09-30$67.70M-$26.50M-$34.40M-$9.50M$0.00-$3.60M-$1.20M*-$4.40M
2022-09-30$412.20M-$24.00M-$8.60M-$4.80M$1.45B$0.00-$1.48B*$330.90M
2021-09-30$456.30M-$39.20M$0.00$0.00$0.00$0.00-$417.10M*$0.00
2020-09-30$498.50M-$41.90M$0.00$0.00$0.00-$456.60M*$0.00

Each quarter (3 month)

Quarter endRunning the businessFrom investingDividendsDebt paid backNew debtStaff share taxNot split outChange in cash
2026-06-30$41.80M*-$129.50M*-$600.00K*-$2.40M*$0.00*$115.40M*
2026-03-31$31.10M*-$500.00K*-$8.90M*-$37.50M*-$100.00K*$5.00M*
2025-12-31$17.20M$9.50M-$8.90M-$37.50M-$4.80M-$24.20M
2025-09-30$84.00M*-$7.30M*-$8.80M*-$72.40M*$0.00*
2025-06-30$81.20M*-$400.00K*-$8.70M*-$52.40M*-$1.10M*
2025-03-31$31.80M*-$100.00K*-$8.70M*-$27.40M*-$900.00K*
2024-12-31-$5.30M-$1.50M-$8.80M-$32.40M-$3.70M-$57.50M
2024-09-30$26.60M*$0.00*-$8.70M*-$27.40M*-$200.00K*
2024-06-30-$2.10M*-$9.70M*-$8.60M*-$2.40M*-$100.00K*
2024-03-31$24.30M*-$3.40M*-$8.60M*-$2.40M*-$500.00K*
2023-12-31-$13.10M-$2.70M-$8.60M-$2.40M-$2.20M-$27.80M
2023-09-30$29.60M*-$9.20M*-$8.60M*-$2.40M*$0.00*-$200.00K*$1.50M*
2023-06-30-$9.30M*-$6.80M*-$8.60M*-$2.30M*$0.00*-$400.00K*-$900.00K*
2023-03-31-$13.00M*-$5.80M*-$17.20M*-$2.40M*-$200.00K*-$900.00K*
2022-12-31$60.40M-$4.70M$0.00-$2.40M-$2.80M-$900.00K*$54.30M
2022-09-30$58.00M*-$8.60M*-$8.60M*-$2.40M*$0.00*$0.00*$3.90M*
2022-06-30$32.80M*-$5.30M*$0.00*-$2.40M*$0.00*$0.00*$5.70M*
2022-03-31$182.60M*-$5.80M*$0.00*$0.00*$90.30M*
2021-12-31$138.80M-$4.30M$0.00$0.00-$134.50M*$0.00
2021-09-30$85.50M*-$13.30M*$0.00*$0.00*-$72.20M*
2021-06-30$129.70M*-$7.70M*-$122.00M*
2021-03-31$119.70M*-$6.30M*-$113.40M*
2020-12-31$121.40M-$11.90M-$109.50M*$0.00

Similar stocks

Stock NameCountryMarket CapPE Ratio
TREACE MEDICAL CONCEPTS, INC. (TMCI)United States$0.297B-4.32
Mobia Medical, Inc. (MOBI)United States$0.293B
TriSalus Life Sciences, Inc. (TLSI)United States$0.283B-9.92
SHOULDER INNOVATIONS, INC. (SI)United States$0.355B
Orchestra BioMed Holdings, Inc. (OBIO)United States$0.356B-4.39
Cytosorbents Corp (CTSO)United States$0.274B-1.29
ORASURE TECHNOLOGIES INC (OSUR)United States$0.272B-6.26
Anika Therapeutics, Inc. (ANIK)United States$0.272B-51.71
Orthofix Medical Inc. (OFIX)$0.373B
InfuSystem Holdings, Inc (INFU)United States$0.253B22.52